[22 May 2013]
Products Affected - Description
Esmolol injection, 10 mg/mL, APP
10 mL single-dose vial, package of 25 (NDC 63323-0652-10)
Reason for the Shortage
- Bedford had esmolol on shortage due to manufacturing delays.
- APP has esmolol on shortage due to increased demand for the product.
Esmolol injection, 10 mg/mL, Baxter
10 mL single-dose vial, package of 25 (NDC 10019-0120-01)
Brevibloc premix, Baxter
10 mL single-dose vial, package of 100 (NDC 10019-0115-01)
10 mg/mL, 250 mL, package of 10 (NDC 10019-0055-61)
20 mg/mL, 100 mL, package of 10 (NDC 10019-0075-87)
Esmolol injection, 10 mg/mL, Bedford
10 mL single-dose vial, package of 10 (NDC 55390-0062-10)
Esmolol injection, 10 mg/mL, Mylan Institutional
10 mL single-dose vial, package of 10 (NDC 67457-0182-10)
Estimated Resupply Dates
- APP has esmolol injection on back order and the company estimates a release date of early-July 2013.
May 22, 2013; May 10, 2013; March 14, 2013; February 13, 2013; January 11, 2013; January 2, 2013; December 14, 2012; November 2, 2012; October 4, 2012; September 12, 2012; July 25, 2012; June 5, 2012; May 21, 2012; May 8, 2012, April 23, 2012; April 12, 2012; April 4, 2012; March 19, 2012; February 29, 2012; February 16, 2012; January 6, 2012; December 2, 2011; October 19, 2011; October 4, 2011; September 21, 2011, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins